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ABSTRACT 
Ongoing concerns exist regarding the dangers inherent when handling cytotoxics, particularly 
drugs which are in parenteral formulations. On occasions, nurses and medical doctors have 
been preparing and administrating these drugs in the open spaces of wards in the absence of 
suitable personal protective equipment (PPE) and safety cabinets. To explore further into the 
severity of occupational hazards, we conducted our research in order to evaluate the 
healthcare’s understanding of occupational exposure to cytotoxics and occurrence of any side 
effects. A cross-sectional study using a self-administered questionnaire was distributed 
amongst oncology nurses in nine specialized cancer centers in Tehran. The questionnaire was 
based on most reputable international guidelines, aiming to evaluate the attitude, knowledge 
and safe practices of nurses' handling cytotoxic drugs. The gathered data and reported side 
effects were compared between “oncology/hematology” and “non-oncology” participants. 
The majority of nurses from oncology wards were aware of the potential hazards associated 
with handling of chemotherapy and reported high levels of compliance with the use of PPE 
during reconstitution of antineoplastic agents. Almost all nurses reported the use of a safety 
cabinet during preparation, however only 55 % reported that they have annual medical check-
ups and 45 % reported having received specialized training. This work was also to evaluate 
the experimental procedures as well as cleaning solutions used to reduce the level exposure. 
While the level of knowledge about antineoplastic agents is high among nurses, along with 
the level of PPE use, medical surveillance and employee training seems to be lagging behind. 
 
Keywords: Cytotoxic drugs, surface sampling, cleaning solutions, contamination, occupa-
tional exposure, questionnaire 
 
 
 
INTRODUCTION 
Hazardous drugs, defined by the Ameri-
can Society of Health System Pharmacists 
(ASHP), are drugs manifesting genotoxicity, 
carcinogenicity, teratogenicity, fertility im-
pairment, serious organ or any other toxic 
manifestation at low doses in animal or hu-
man experiments (ASHP, 1985). Cytotoxic 
drugs, sometimes known as antineoplastic, 
anticancer or cancer chemotherapy drugs are 
defined as hazardous drugs (Ansari Lari et 
al., 2001). Their pharmacological property to 
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kill tumor cells is by interfering with cell di-
vision. However, their action is not specific 
to cancerous cells, and non-cancerous cells 
may also get damaged (Barton Burke and 
Wilkes, 2006). As a result, they can induce 
significant side effects in patients or any oth-
er person exposed to them in the treatment 
chain. The medical, clinical, nursing team 
and workers are exposed to hazardous drugs 
throughout their career cycle (Gambrell and 
Moore, 2006). They are involved in manu-
facturing transport, distribution, use in health 
care setting and waste disposal (Connor and 
McDiarmid, 2006; Zeedijk et al., 2005). 
Acute exposure generally causes transient 
symptoms such as headache, nausea, ma-
laise, dizziness, rash, dermatitis, skin and 
mucous membrane irritation or ulceration 
and eye or throat irritation. The side effects 
of repeated exposure are significant and dan-
gerous (Valanis et al., 1993a). This together 
with the increasing complexity of chemo-
therapy, have raised the concerns about the 
risks to health care workers who are in-
volved in this cycle.  
Falck et al. (1979) first reported the evi-
dence of mutagenicity in urine samples of 
the nurses handling cytotoxic drugs. Other 
studies have found increased chromosomal 
aberrations and evidences of mutagen-
ic/carcinogenic risks in exposed nurses’ 
urine samples (Terui et al., 2011; Moretti et 
al., 2011; Suspiro and Prista, 2011; Ursini et 
al., 2006; Kopjar et al., 2010). Fetal loss in-
duced by chronic exposure to cyclophos-
phamide, doxorubicin and vincristine, in 
nursing personnel was also observed (Sele-
van et al., 1985). The report of learning disa-
bilities in children of nurses who had han-
dled chemotherapy drugs was provided by a 
study of Martin (2005). Numerous studies 
have been published that have demonstrated 
contamination of workplace with antineo-
plastic drugs (Hedmer et al., 2005, 2008; 
Zeedijk et al., 2005; Mason et al., 2003; 
Maeda et al., 2010; Acampora et al., 2005), 
use of analytical methods to determine con-
tamination concentration level in surface 
(Turci et al., 2002) and evaluation of pattern 
of use of personal protective equipment and 
compared with current guidelines (Martin 
and Larson, 2003; Polovich and Martin, 
2011; Krstev et al., 2003). Hepatic injuries 
can also develop, but some other studies 
have failed to support a relation between ex-
posure and this particular problem. During 
the past 30 years, professional organizations 
and government agencies have developed 
guidelines to protect health care workers 
from adverse effects of occupational expo-
sure to antineoplastic drugs. The occupation-
al exposure to antineoplastic drugs is directly 
linked to the poor effectiveness of cleaning 
procedures or indeed the solutions used for 
cleaning the work surface (Lé et al., 2013). 
Various agencies and organizations include 
the US Department of Labor’s Occupational 
Safety and Health Administration (US De-
partment of Labor, 1995), the National Insti-
tute for Occupational Safety and Health 
(NIOSH, 1988), the Oncology Nursing Soci-
ety (Brown et al., 2001), the American Soci-
ety of Health System Pharmacists (ASHP), 
and the American Medical Association’s 
Council on Scientific Affairs (AMA, 1985) 
do jointly express concerns about failure in 
cleaning procedures and recommend a need 
for validated cleaning protocol standards. 
Previous studies of outpatient and office-
based health care workers in Iran show weak 
compliance of their practice with safe-
handling guidelines (Ansari Lari et al., 
2001). In addition, since nurses and medical 
doctors have been preparing these cytotoxic 
drugs in the open spaces of wards in the ab-
sence of appropriate garments and personal 
protective equipment, it is important to eval-
uate the current system and the risks associ-
ated with the exposure to the cytotoxic drugs 
in these centers. 
 
MATERIALS AND METHODS 
Site observation 
The visiting report was conducted at var-
ious specialized cancer centers in Tehran, in 
order to determine the severity of occupa-
tional hazards. The exposure of health care 
workers to antineoplastic drugs during pre-
paration and administration was the main 
consideration. This study was one of the 
EXCLI Journal 2014;13:491-501 – ISSN 1611-2156 
Received: December 20, 2013, accepted: May 08, 2014, published: May 09, 2014 
 
493 
largest studies in its own right as nine pro-
fessional and specialized cancer centers in 
Tehran (governmental and private centers) 
were selected. Although, there are in excess 
of thirty five known cancer treatment centers 
in Tehran but these selected centers are cho-
sen purely based on the fact that they had the 
participant’s recruitment criteria for our 
study and are known as the most reputable 
cancer centers with good practicing habits in 
the capital city. These centers were studied 
through an on-the-spot investigation and data 
were analyzed in terms of being consisted 
and close to the standards. Observations 
were conducted in order to predict how and 
where (at what stages) nurses would be ex-
posed to antineoplastic drugs. 
 
Population recruitment 
A total number of 225 rotational nursing 
staffs were provided with the questionnaire, 
among 152 women and 73 men. All the par-
ticipants were working at least for 12 months 
as a fully registered nurse, rotating in “on-
cology/hematology” for a period of no less 
than six months compared in parallel with 
the nurses from “non-oncological” wards 
with no exposure to the cytotoxic drugs. The 
participants in both groups were approxi-
mately similar in terms of sex and number of 
years of experience with the median age of 
37.3 years old. Exclusion criteria were: ac-
tive drinkers or smokers, known uncon-
trolled chronic medical conditions (cardiac 
problems, diabetes, arthritic related disorders 
and respiratory diseases), bleeding disorders, 
any past cancer diagnosis or active compli-
cated medical or surgical therapies in the 
past 12 months. The aim of this stringent se-
lection in terms of health and age was to 
avoid any bias or any unrelated symptoms 
reporting by the nursing staff. Demographic 
details of all participants in this study are 
shown in Table 1. 
Table 1: Demographic information of nursing 
staff participating in the study 
Characteristic  
( %) of Respondents 
(n = 225) 
Gender 
  Female 
  Male  
 
67.5 
32.5 
Marital status 
  Single 
  Married 
 
10 
90 
Non-oncological  
experiences (years) 
  1-5 
  6-10 
  11-20 
  21 or more 
 
 
5 
22 
68 
5 
Oncological/hema-
tology experiences 
(years) 
  1-5 
  6-10 
  11-20 
  21 or more 
 
 
 
37 
30 
26 
7 
 
 
Questionnaire  
The questionnaire was in two parts and 
based on the most reputable international 
guidelines such as American Society of 
Health System Pharmacists (ASHP), the Oc-
cupational Safety and Health Administration 
(OSHA) and the Health & Safety Executive 
(HSE-UK) guidelines for handling cytotoxic 
drugs in clinical settings. First part was 
aimed to establish the participant’s under-
standings of hazards associated with their 
jobs and existence or lack of resources to 
help them to minimize such risks. The se-
cond part was aimed at gathering any report-
ed side effects which may be due to acute or 
chronic exposure to cytotoxic. Acute side 
effects were classified as irritation of mucous 
membranes, eyes and skin, dizziness, head-
ache, nausea and vomiting. The question-
naire had to be specific without causing any 
concerns for participants when answering the 
questions. The questions had to be translated 
from English to Persian without any loss of 
meaning, therefore, expert opinions were 
considered and once the translation was 
completed, the questionnaire was validated. 
The validation process was simply by vari-
ous pilot studies, cross referencing to clarify 
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the participant’s understandings and ulti-
mately analyzing the findings and compari-
son against the guidelines recommendations. 
 
Surface sampling and analysis 
Surface wipe samples were taken from 
the surface of the cabinets or isolators (where 
the drugs were prepared) before and after 
cleaning, as recommended by the interna-
tional standards. The method was adopted 
from previous works (Ziegler et al., 2002). 
The samples from surfaces were taken by 
wiping thoroughly the surface with sterile 
gauze (10 cm×10 cm) which had been wet-
ted with 5 ml of 30 mM sodium hydroxide. 
All samples were collected into the separate 
sealed plastic boxes and kept at -18 °C be-
fore the analysis. The formic acid with the 
PH of 3 (5 ml) was added to each sample. 
The prepared samples were then sonicated 
and injected in to the HPLC. Analyses were 
carried out with the HPLC system model 
SPDM-10ADvp from Shimadzu (Kyoto, Ja-
pan) consisting of LC-10Advp binary pumps, 
a SCL-10Avp controller, a SPD-M10Avp 
PDA detector and a DGU-14A degasser 
model and operated with Class-VP software 
(Shimadzu Scientific instruments, Inc.). Sep-
arations were done on a C18-M51002546 
250 × 4.6 mm column from Hector (Venture 
Town, South Korea). The mobile phase used 
for chromatography was formic acid with the 
PH of 3, with a wavelength of 200 and flow 
rate of 1.4. The selectivity of the method and 
accurate recognition of the substance (5-FU) 
was verified by the UV spectra. 
 
Deactivator or cleaning solutions 
We are proposing that one of the reasons 
for exposure to these drugs is the lack of 
suitable deactivator or cleaning solution in 
our investigated centers or indeed the lack of 
existence of standard cleaning protocols. 
New combinations of deactivating and clean-
ing agents were used and comparison be-
tween the current brands and recommended 
cleaning solutions were made. The most 
used agents are Na Hypochlorite, sterile wa-
ter, isopropyl alcohol 70 %, hydrogen perox-
ide and alkaline cleaning agents. These solu-
tions were used alone or in combination with 
each other. The surface sampling was done 
before and after cytotoxic drugs preparations 
using the identical standard operating proce-
dure for cleaning the surface. The results 
were then compared bearing in mind the var-
iations in cleaning solutions and following a 
proper cleaning standard operating proce-
dure. 
 
Chemicals and materials 
5-Fluorouracil was purchased from 
Kocak Farma (Tekirdag, Turkey). Sodium 
hydroxide was from Merck KGaA (Darm-
stadt, Germany). Formic acid was obtained 
from Merck Schuchardt OHG (Hohenbrunn, 
Germany). Na Hypochlorite was purchased 
from Tizpak (Khorasan, Iran), Isopropyl Al-
cohol was from Sepidaj (Tehran, Iran), hy-
drogen peroxide was from Merck KGaA 
(Darmstadt, Germany) and Triethanolamine 
was from Sinchem (Dongguo, Tengzhou, 
Shandong, China). 
 
RESULTS 
In this cross-sectional study, the site ob-
servation was performed on multiple days 
and on different individuals in order to de-
termine the risk of exposure, and the poten-
tial contaminated work surfaces at each side 
of the hospital. List of all cytotoxic drugs 
used in these centers were obtained and the 
most common ones were classified based on 
International Agency for Research on Cancer 
(IARC, 1981) (Table 2).  
The work force studies were carried out 
in each center and compared with the re-
commendations by the guidelines. Recom-
mendations on training, transport, type of 
isolators and maintenance of the clean room 
were compared with our centers (Table 3). 
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Table 2: Classification of common cytotoxic agents based on IARC 
Cytotoxic Drugs IARC classifications * Frequency % # Contact exposure  %
Methotrexate 3 43.6 68 
5-Fluorouracil 3 42.7 67.3 
Cyclophosphamide 1 30 41.2 
Cisplatin 2A 18 24.3 
MOPP regimen 1 16 21.6 
Etoposide 1 11.1 11.3 
Busulfan 1 9.7 6.5 
Mitomycin C 2B 8.3 6 
Bleomycins 2B 7.2 5.4 
Adriamycin 2A 4.3 3.7 
Vinblastine 3 4.1 3.6 
Dacarbazine 2B 3.8 3 
Melphalan 1 3.5 2.7 
Group 1: carcinogenic to human 
Group 2A: probably carcinogenic to humans 
Group 2B: possibly carcinogenic to humans 
Group 3: not classifiable as to its carcinogenicity to humans 
*Frequency: % of days in which drugs were used in six months 
#Average percentage of contact exposure: calculated based on shift patterns, time of preparations and administrations on a 
daily basis for a period of six months 
MOPP regimen: Mechlorethamine, Vincristine (Oncovin), Procarbazine, Prednisone  
 
 
Table 3: Comparison of recommendations by the guidelines against practices in cancer centers 
 Hospital practices AHSP/OSHA/HSE
No. of nurses employed 
in cytotoxic preparations 
All nurses employed in 
Onc/Haem wards (no 
specific defined clinical 
governance) 
Based on clinical governance  
Average no. of drug 
preparations for each 
nurse 
14-26/day No specific numbers. Based on individual center’s work-
force 
Specific training courses 
arranged by hospitals 
Almost every 6 months 
theoretical training, but 
not in all centers 
Training on the adverse effects of cytotoxic drugs and 
the potential of long-term health risk. Each individual’s 
knowledge and technique should be evaluated. Written 
examination and direct observation of the individual’s 
performance is needed. All staff who will be compound-
ing hazardous drugs must be trained in the stringent 
aseptic and negative-pressure techniques necessary for 
working with sterile hazardous drugs. 
Trained staff must demonstrate competence by an objec-
tive method, and competency must be reassessed on a 
regular basis. 
Drug transfer to wards Nurses by hand Drug transfer from aseptic unit by trained porters 
Types of hoods Vertical laminar flow, any 
biological-safety cabinet 
Negative-pressure isolators, Class II biological-safety 
cabinet 
Frequency of cleaning 
workbench in a day 
Usually once after prepa-
rations in every shift 
At least twice daily 
Detergent used for 
cleaning purposes 
Saline, Alcohol  Sterile Alcohol, Sterile water, Peroxide, Sodium hypo-
chlorite solutions 
Use of modalities to 
avoid drug spread 
Non observed Fully described by all guidelines 
Floor and furniture clean-
ing 
Very infrequent (in one 
center no cleaning was 
done) 
Ventilated cabinet should be cleaned two or three times 
daily for 24 hours service. Once weekly wall cleaning and 
once monthly wall and ceiling cleaning  
Individual protective 
measures 
Thin plastic cover or 
gown, protective goggle, 
powder free latex, double 
layer surgical mask were 
supplied but their use 
was infrequent by nurses 
Double nitrile, powder free gloves are preferred.  
Disposable Gown made with long sleeves and tight-fitting 
elastic or knit cuffs  
Respiratory protection 
Eye protection: face shield, splash goggles 
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Using the validated questionnaire, we 
aimed to investigate the prevalence of acute 
adverse effects. The oncology/hematology 
rotational nursing staffs (rotation in various 
medical/surgical as well as oncology/hema-
tology specialties) were compared in parallel 
to the “non-oncology” nursing staff referred 
as a control group. An acute adverse effect 
such as skin irritation is the most reported 
one (38 %) by the nurses working in the on-
cology units in comparison to the control. 
Skin irritation could be any rash and skin 
redness (dermatitis like reactions) while 
working with cytotoxic agents. In all cases 
nurses confirmed that they had no other rea-
sons or life style changes to be the cause for 
such reactions. Other reported acute adverse 
effects by this group of nurses in order were 
hair loss with 33 % of the nurses reporting 
and nausea and vomiting with 26 %. The 
questions presented to the nurses were; “In 
general, have you experienced more episodes 
of hair loss while working in your current 
wards?” and “In general, have you experi-
enced more episodes of nausea and vomiting 
while working in your current ward?” The 
results of comparing symptoms associated 
with occupational exposure to chemotherapy 
agents in both, exposed and control group 
are indicated in Table 4.  
One of the reasons for exposure could be 
due to use of inappropriate cleaning solu-
tions. Therefore, the common cleaning and 
deactivating solutions were used to compare 
the ability for reduction of contamination. 
Sodium hypochlorite was the only solution 
with the highest level of reduction and its 
combination with sterile IPA 70 % in equal 
parts was the next one in line. The least level 
of reduction was by using the Triethanola-
mine with the reduction value of 71.5 %. The 
only “cleaning solution brand” used in the 
cancer centers contains Propan-1-ol, Propan-
2-ol, Mecetronium ethyl sulfate with the 
ability of contamination reduction of 77 % 
(Table 5).  
In order to investigate the training ar-
rangements and the sources of such train-
ings, the questionnaire included both direct 
and open questions to establish the exact 
sources. 52 % of nurses received information 
about cytotoxic drugs from text books and 
internet, 27 % from nursing associations and 
previous undergraduate training. Training 
obtained from nursing co-workers was re-
ported by 14 % of the nurses and participa-
tion in conferences was 3 %. Respectively, a 
minute level, 4 % of the nurses received 
training program from the clinical settings 
directly while working as a nursing staff 
(Table 6). 
There was very limited training materials 
offered for nursing staff to read on or indeed 
any specific continues profession develop-
ment (CPD). The phrase “CPD” was unfa-
miliar to 63 % of the registered nursing staff 
participating in our investigation. However, 
they all acknowledged that professional de-
velopment was always strongly recommend-
ed by the university lecturers and by many 
medical professional working alongside of 
nurses such as pharmacists and medical doc-
tors. The lack of time, encouragement and 
limitation in number of staffing was a major 
reason for not being able to take on further 
CPD shared by all the participants. 
 
 
          Table 4: Acute adverse effects reported by nursing staff using questionnaire  
Groups Hair loss Skin irritation Nausea and vomiting 
Oncology/hematology 33 % 38 % 26 % 
Control 8 % 4.5 % 5.5 % 
P-value 0.001 0.000 0.01 
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Table 5: Comparison of common cleaning solutions using the HPLC method 
Concentration 
before cleaning 
(μg/cm2) 
Solution used for cleaning Concentration 
after cleaning 
(μg/cm2) 
Reduction of  
contamination 
(%) 
20.0 Na hypochlorite ND a 100 % 
22.4 Na hypochlorite:IPA70 % (50:50) 0.2 98.8 % 
1.2 H2O2+IPA+deionized water 0.0 97.5 % 
15.0 IPA70 % 0.5 96 % 
0.2 H2O2 0.0 93.7 % 
9.4 The only Brand used in cancer 
centers (Propan-1-ol, Propan-2-ol, 
Mecetronium ethyl sulfate)  
2.1 77 % 
9.5 H2O2+TEA 2.6 72 % 
2.4 Triethanolamine 0.7 71.5 % 
a Not detectable.  
Surface sampling (average of three) was taken randomly from the surface of the isolators/cabinets where the preparations of 
cytotoxic drugs were taking place. The method (adopted from Ziegler et al., 2002), before cleaning in comparison to the after 
cleaning of the isolator surfaces (as described in our method section).  
 
 
Table 6: Training methods on handling, manufacturing, administrating and disposing cytotoxic agents 
for nursing staff 
Questions  Response (%) 
Classes and training held by the hospitals 4 
Participation in conferences 3 
Information obtained from coworkers 14 
Nursing associations and previous university training (during under-
graduate training) 
27 
Individual studies using various texts and internet 52 
 
 
DISCUSSION 
To the best of our knowledge the pre-
sented manuscript is one of the most exten-
sive investigational studies in its own right 
including the large number of participants 
and tackling occupational exposure in the 
healthcare setting. The selected cancer cen-
ters in the capital city of Iran were offering 
the appropriate participants as well as being 
known as the premium cancer centers. The 
aim of this investigation was to evaluate the 
current practices of nursing staff working in 
the oncology units and the level of exposure 
to cytotoxic agents. This study was objective 
in all aspects and was carried out in four dif-
ferent parts; 
(i) To investigate the procedure of cyto-
toxic drug preparation and administration in 
comparison to the guidelines  
(ii) Assess the level of training and 
knowledge of the nurses on risks associated 
with cytotoxic exposure and their actual us-
age of safety measures 
(iii) Investigate and compare the level of 
acute side effects that were associated with 
occupational exposure to chemotherapy 
agents in comparison to those working in 
non-oncological units 
(iv) Evaluate the current cleaning proce-
dures and cleaning solutions against the re-
commended suitable cleaning and deactiva-
tor solution.  
Increasing utilization of chemotherapeu-
tic agents in treating patients with malignan-
cy has led to the potential for widespread 
exposure of healthcare workers who come 
into contact with patients or these agents in 
the work place. Unfortunately, these drugs 
are toxic to both the abnormal and normal 
somatic cells. This occurs in the patient, and 
is also likely to affect any individual who is 
exposed. There appear to be widely diver-
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gent opinions concerning the extent of haz-
ard of coming into contact with these agents, 
in spite of which caution and minimizing ex-
posure risk seems only prudent and appro-
priate. The known cytotoxic agents are clas-
sified by the International Agency for Re-
search on Cancer based on the carcinogenici-
ty to the human due to exposure (Table 2). 
Consumption or administration, direct con-
tact and inhalation are referred as the main 
exposure routes (IARC, 1981). Our results 
show for instance, nursing staff (working 40 
hours a week for a period of six months) are 
exposed to group 1 classified agents (car-
cinogenic to human) in the oncology units 
with contact exposure between 2.7 % for 
preparing Melphalan to 41.2 % for preparing 
Cyclophosphamide. Therefore, initially it is 
suggested that factors in preparation area like 
hood type, coverage plan, inlet and outlet 
filters, and filters replacement are important 
to reduce the exposure (Kopjar et al., 2009). 
All employees exposed to chemotherapy 
agents require wearing the job specific re-
commended level of PPE as the guidelines. 
Furthermore, the cleaning procedures condi-
tion in the preparation and administration 
areas like appropriate space, exclusive use, 
access restrictions, presence of warning 
signs, dressing room, sinks, eyewash, show-
er, adequate lightening and ventilation, mi-
croclimate conditions, intact floor and walls 
are also important to be considered (Sessink 
et al., 1994). 
Our results indicate that the level of 
knowledge of the nurses on the risks of ex-
posure is satisfactory. However, the usages 
of safety measures are not as recommended 
by the mentioned guidelines (Table 3). Simi-
larly, other studies have reported that nurses 
handling the cytotoxic drugs don’t have sat-
isfactory level of knowledge about the risks 
(Habib and Karam, 1992). The lack of 
knowledge on preventive measures is very 
much the point of concern as it increases the 
health workers’ health and safety. Usually by 
participating in training programs, the level 
of knowledge will significantly improve and 
the safe practice is more likely to happen 
(Sessink et al., 1997). Furthermore, occupa-
tional safety and health administration guide-
lines state that training of all staff involved 
in any aspect of the handling of hazardous 
drugs is essential (IARC, 1981).  
The nurses’ safe practice and the usage 
of recommended health safety measures are 
directly associated with the individual beliefs 
rather than the rules and regulations pertain-
ing to the cytotoxic drugs. Other studies had 
similar findings where beliefs about “what 
protection was required” had stronger corre-
lation with actual use than policy content in 
relation to the cytotoxic protection (Martin 
and Larson, 2003). However, eating or 
drinking was strictly forbidden in the prepa-
ration room or indeed anywhere cytotoxic 
drugs were handled or prepared. In compari-
son, other studies did disclose that eating or 
even smoking was observed in the similar 
clinical settings (Aydemir et al., 2003). The 
findings about the use of personal protective 
equipment showed that all of the nurses were 
using some protective equipment necessary 
during the handling of cytotoxic drugs. For 
instance, all nurses were using gloves, masks 
and gown when preparing the chemothera-
peutic agents albeit not the exact recom-
mended types by the guidelines (Al-Ghamdi 
and Al-Mustafa, 1997).  
Questionnaire data on work practices, 
potential exposure, extent of side effects, use 
of protective personal equipment and rele-
vant training were collected from all grades 
of nursing staff and evaluated. For occupa-
tional health services it is important to have 
sensitive and specific methods for monitor-
ing exposure to cytotoxic drugs (Kopjar et 
al., 2009). The medical surveillance program 
should include general health questionnaires 
that should be completed upon hire, periodi-
cally (such as yearly), and at job termination. 
In our centers and in many developing coun-
tries no such questionnaires were offered, 
however, when such questionnaires were of-
fered, no objections were made by the clini-
cal setting’s director (Chaudhary and Karn, 
2012). Therefore, this could be argued that 
this level of ignorance is not intentional and 
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is due to lack of knowledge or resources to 
deal with this type of issues. In majority of 
developed countries, clinical or hospital 
pharmacists are heavily and actively in-
volved in staff training and aseptic manufac-
turing activities and management (Castiglia 
et al., 2008). The questionnaires were used to 
identify the level of exposures and reported 
acute side effects. In our recruited popula-
tion, one of the most common acute side ef-
fects such as skin irritations were reported in 
38 % of all oncology/hematology group in 
comparison to only 4.5 % of the reported 
cases in control group. Likewise, other acute 
side effects such as hair loss as well as nau-
sea and vomiting were significantly higher 
(Valanis et al., 1993b). This extraordinary 
level of acute adverse reporting was due to 
the fact that participating oncolo-
gy/hematology nursing staff were also rotat-
ing in various specialties and each were 
comparing their own adverse effect experi-
ences between oncology and non-oncology 
rotations (Table 4). In similar pattern with 
other studies, the most prominent reported 
side effect was skin irritation when the same 
number of female participants were consid-
ered (Valanis et al., 1993b). In male partici-
pants, the hair loss was the most reported 
side effects with the average number of 8 % 
of the male nurse participants. Overall, the 
number of oncology/hematology nurses 
complaining of acute side effects due to oc-
cupational exposure to drugs in male and 
female participants was significantly higher 
when compared against those in control 
group (Valanis et al., 1993a, b). Due to its 
importance, in many developed countries 
following the strict in house guidelines a 
complete blood count with differential and 
additional tests such as liver function test are 
required for those at risk of cytotoxic expo-
sure (Sessink et al., 1994).  
The contamination rate of 5FU as the 
most commonly used drug in these centers 
was measured. The sample locations includ-
ed places in the cytotoxic production area 
such as working surfaces, in the storage and 
checking room, refrigerator and storage 
shelves. The traces of 5FU were commonly 
detected in our samples. Most of the contam-
ination was found inside the laminar flow or 
safety cabinets (Ziegler et al., 2002). This 
finding could be expounded by the facts that 
nurses are not trained and monitored for their 
expertise on reconstitutions of cytotoxic 
drugs and not using the appropriate cleaning 
solutions (Table 5). In similar studies 
(Acampora et al., 2005; Castiglia et al., 
2008), it was proposed that the nursing staff 
were exposed to the cytotoxic surface con-
tamination due to the haphazard working 
practices and cleaning procedures. 
The health care setting managers do not 
seem to be acting proactively when it comes 
to staff training and in some studies it has 
been suggested that the hospitals do the min-
imum requirement to get away with the regu-
lations (Sessink et al., 1994; Krstev et al., 
2003). The main source of information for 
more than half of participants (52 %) re-
mains to be the individual readings either 
from the text books or searching through the 
internet (Table 6). This level of reliant can be 
very risky as the extent of searches can vary 
between the individual nursing staff and ma-
jority of available information are in English 
language where many nurses are unfamiliar 
with it. The staff training should be conduct-
ed before beginning duties, at least yearly or 
more often if deficiencies are observed. The 
level of detail and complexity of training 
should be tailored to the specific job area.  
This study suggests that although the ex-
act existing guidelines are not compatible to 
be followed in our centers, but with some 
modifications, major improvements will be 
possible. Data from the validated question-
naires are strongly linking the risk of occu-
pational hazard and current practices. The 
reported adverse effects as a result of current 
exposure are apparent. In order to reduce the 
contamination in the working areas, immedi-
ate actions should be taken. More efficient 
cleaning procedure with the use of proper 
cleaning solvents and enhanced cleaning fre-
quencies should be offered. Ultimately, prac-
tical suggestions and training from the clini-
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cal and aseptic pharmacists will significantly 
improve the current system.  
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